-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Centessa Pharmaceuticals to Peer Perform

Benzinga·03/31/2026 15:36:54
Listen to the news
Wolfe Research analyst Rudy Li downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Outperform to Peer Perform.